ALEX THOMAS: Open Payments
NPI 1336171008 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 28 payments from 8 companies in 2025. Trend: 2023 $1,016 · 2024 $805 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $239 |
| Alkermes, Inc. | 5 | $128 |
| ABBVIE INC. | 6 | $124 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Lundbeck LLC | 1 | $25 |
Products named: COBENFY, ARISTADA, VRAYLAR, INGREZZA, CAPLYTA, AUSTEDO XR, REXULTI, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
